Contact Us
Drug Search Results
More Filters [+]

Sacrosidase

Alternative Names: sacrosidase, sucraid
Latest Update: 2024-02-06
Latest Update Note: Clinical Trial Update

Product Description

a liquid produced from Saccharomyces cerevisiae containing 6000 IU of sucrase activity per mg protein. Sacrosidase is a safe, effective, well-accepted treatment to prevent gastrointestinal symptoms in patients with CSID consuming a normal diet. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/9932843/)

Mechanisms of Action: Disaccharide Metabolizer

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Korea | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: QOL Medical
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sacrosidase

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Celiac Disease|Cross Infection|Protein Deficiency

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
SSDXA-14

P2

Completed

Protein Deficiency|Cross Infection|Celiac Disease

2024-01-22

24%

Recent News Events

Date

Type

Title

09/06/2022

News Article

 QOL Medical, LLC receives FDA approval of Sucraid® (sacrosidase) Oral Solution single-use containers for patients with Congenital Sucrase-Isomaltase Deficiency (CSID)

04/15/2022

News Article

 QOL Medical, LLC Selects Optum Frontier Therapies as an Exclusive Pharmacy Partner to Best Support Congenital Sucrase-Isomaltase Deficiency (CSID) Patients on Sucraid® (sacrosidase) Oral Solution

08/06/2020

News Article

 Hypomorphic Genetic Variants Associated With Childhood Chronic Loose Stools

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions